Status | Study |
Not yet recruiting |
Study Name: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma Condition: Alveolar Soft Part Sarcoma Leiomyosarcoma Date: 2017-01-06 Interventions: Drug: AL 3818 Other Name: Anlo |
Recruiting |
Study Name: Detection of Circulating Tumor Cells in Patients With Sarcomas Condition: Leiomyosarcoma Pleomorphic Liposarcoma Date: 2016-10-27 |
Recruiting |
Study Name: DHEA in Synovial Sarcoma Patients Condition: Synovial Sarcoma Sarcoma, Synovial Date: 2016-02-11 Interventions: Drug: DHEA Other Name: Dehydro |
Recruiting |
Study Name: Trial of CMB305 and Atezolizumab in Patients With Sarcoma Condition: Sarcoma Myxoid/Round Cell Liposarcoma Date: 2015-11-14 Interventions: Biological: CMB305 CMB305 is a |
Recruiting |
Study Name: A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma Condition: Rhabdoid Tumors INI1-negative Tumors Date: 2015-10-21 Interventions: Drug: Tazemetostat Tazemetostat (EPZ-6438) is a selective small molecule inhibitor of the histone-lysine |
Recruiting |
Study Name: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Condition: Malignant Rhabdoid Tumors (MRT) Rhabdoid Tumors of the Kidney (RTK) Date: 2015-10-21 Interventions: Drug: Tazemetostat Tazemetostat (EPZ-6438) is a selective small molecule inhibitor of the histone-lysine |
Active, not recruiting |
Study Name: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma Condition: Pleuropulmonary Blastoma Recurrent Malignant Peripheral Nerve Sheath Tumor Date: 2015-05-20 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Whole Lung IMRT in Children and Adults With Synovial Sarcoma and Lung Metastases Condition: Synovial Sarcoma Single or Multiple Lung Metastases Date: 2014-07-02 Interventions: Radiation: Whole Lung IMRT External beam radiation therapy will be administered on an outpatient basis, |
Withdrawn |
Study Name: NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma Condition: Adult Synovial Sarcoma Myxoid/Round Cell Liposarcoma Date: 2014-02-07 Interventions: Biological: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes |
Recruiting |
Study Name: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer Condition: Synovial Sarcoma Breast Cancer Date: 2013-10-18 Interventions: Biological: Anti-NY ESO-1 mTCR PBL |